TLR3 and neoplasm: MSCs that have been primed with TLR4 are referred to as MSC1 and display an antitumorigenic effect, while MSCs that have been primed with TLR3 are known as MSC2 and have a tumor-supportive role (Figure 1B) (Waterman et al., 2012).